TO IDENTIFY, EVALUATE, AND ANALYZE THE POSSIBLE DRUG-DRUG INTERACTIONS IN PATIENTS DIAGNOSED AS TYPE 2 DIABETES MELLITUS WITH HYPERTENSION IN A TERTIARY CARE TEACHING HOSPITAL
Abstract
Objective: To identify, evaluate, and analyze the possible drug-drug interactions (DDIs) in patients diagnosed as Type 2 diabetes mellitus with
hypertension in a tertiary care teaching hospital Davangere.
Methods: This prospective interventional study was conducted for a period of 6 months. Data were collected from patients who were prescribed with
at least one antidiabetic drug and at least one antihypertensive drug at the same time. Data were analyzed for DDIs by using software Micromedex and
other resources. Results were notified to the physicians for modification or alteration in the drug therapy.
Results: A total of 150 patients were analyzed out of which, 60.67% were male, and the rest 39.33% were female. In terms of interactions present,
95 (63.33%) prescriptions had one or more interactions. Antihypertensive drugs most frequently seen in prescriptions were diuretics (24.44%). Antidiabetic
drugs seen frequently prescribed are biguanides (34.36%). A total of 167 possible DDIs were obtained. Angiotensin-converting enzyme inhibitors were
most frequently involved antihypertensive drug in DDIs, with 60 of all possible DDIs identified. Insulin and biguanides were most frequently involved
antidiabetic drugs in DDIs, with 58 each of all possible DDIs identified. Most frequently interacting drug pair was insulin + metformin (n=19).
Conclusion: For every possible DDIs found in the prescription, the appropriate intervention was advised from the investigator's part as well as
provision for a physician to review and initiate modification of his choice.
Keywords: Hypertension, Possible drug-drug interaction, Type 2 diabetes mellitus.
Â
Downloads
References
Zaman Huri H, Fun Wee H. Drug related problems in type 2 diabetes
patients with hypertension: A cross-sectional retrospective study. BMC
Endocr Disord 2013;13:2.
Parameshappa B, Rao VN, Gouda ST, Sen S, Chakraborty R, Basha AN,
et al. A study on drug-drug interaction between anti-hypertensive
drug (Propranolol) and anti-diabetic drug (Glipizide). Ann Biol Res
;1(3):35-40.
Triplitt C. Drug interaction of medications commonly used in diabetes.
Diabetes Spectr 2006;19(4):202-11.
Stults B, Jones RE. Management of hypertension in diabetes. Diabetes
Spectr 2006;19:25-31.
Cooper–DeHoff RM, Bird ST, Nichols GA, Delaney JA, Winterstein AG.
Antihypertensive drug class interactions and risk for incident diabetes:
A nested case-control study. J Am Heart Assoc 2013;2(3):e000125.
Karagiannis A, Tziomalos K, Pagourelias ED, Gossios TD, Athyros VG.
Effect of antihypertensive drug-associated diabetes on cardiovascular
risk. Hellenic J Cardiol 2010;51(3):195-9.
Wood AJ. Drug interactions in hypertension. Am Heart Assoc
;11(3):1-3.
Neto CV, Garcia PV, Helena ST. Possible pharmacological interactions
in hypertensive and/or diabetic elderly in family health units At
Blumenau (SC). Braz J Pharm Sci 2010;46(4):795-804.
Arauz-Pacheco C, Parrott MA, Raskin P. The treatment of hypertension
in adult patients with diabetes. Diabetes Care 2002;25(1):134-47.
Arya SN. Hypertension in diabetic patients – Emerging trends. J Indian
Acad Clin Med 2003;4(2):96-102.
Whalen KL, Stewart RD. Pharmacologic management of hypertension
in patients with diabetes. Am Fam Physician 2008;78(11):1277-82.
Rafiei H, Arab M, Ranjbar H, Sepehrig G, Arab N, Amiri M. The
prevalence of potential drug-drug interactions in intensive care units.
Iran J Crit Care Nurs 2012;4(4):191-6.
Mateti U, Rajakannan T, Nekkanti H, Rajesh V, Mallaysamy S,
Ramachandran P. Drug-drug interactions in hospitalized cardiac
patients. J Young Pharm 2011;3(4):329-33.
Mallet L, Spinewine A, Huang A. The challenge of managing drug
interactions in elderly people. J Med 2007;320:185-91.
Mirosevic Skvrce N, Macolic Sarinic V, Mucalo I, Krnic D,
Bozina N, Tomic S. Adverse drug reactions caused by drug-drug
interactions reported to Croatian Agency for Medicinal Products and
Medical Devices: A retrospective observational study. Croat Med J
;52(5):604-14.
Obreli Neto PR, Nobili A, Marusic S, Pilger D, Guidoni CM, Baldoni
Ade O, et al. Prevalence and predictors of potential drug-drug
interactions in the elderly: A cross-sectional study in the Brazilian
primary public health system. J Pharm Pharm Sci 2012;15(2):344-54.
Jimmy OD, Shobha R, Indira R, Ramjan S. Study of drug-drug
interactions in the medication charts in medicine wards at a tertiary care
hospital, Bangalore. Indian J Pharm Pract 2012;5(4):61-4.
Mahendra KB, Kumaraswamy M, Mahadevamma L. Incidence
and pattern of potential drug interactions of antimicrobial agents
in the Department of medicine in a tertiary care teaching hospital:
A prospective study. Asian J Pharm Clin Res 2011;4(2):31-6.
Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, et al.
A population-based study of the drug interaction between proton pump
inhibitors and clopidogrel. CMAJ 2009;180(7):713-8.
Moura CS, Acurcio FA, Belo NO. Drug-drug interactions associated
with length of stay and cost of hospitalization. J Pharm Pharm Sci
;12(3):266-72.
Reis AM, Cassiani SH. Prevalence of potential drug interactions in
patients in an intensive care unit of a university hospital in Brazil.
Clinics (Sao Paulo) 2011;66(1):9-15.
Sharma S, Chhetri HP, Alam K. A study of potential drug-drug
interactions among hospitalized cardiac patients in a teaching hospital
in Western Nepal. Indian J Pharmacol 2014;46(2):152-6.
Delaney JA, Opatrny L, Brophy JM, Suissa S. Drug drug interactions
between antithrombotic medications and the risk of gastrointestinal
bleeding. CMAJ 2007;177(4):347-51.
Cruciol-Souza JM, Thomson JC. Prevalence of potential drug-drug
interactions and its associated factors in a Brazilian teaching hospital.
J Pharm Pharm Sci 2006;9(3):427-33.
Chelkeba L, Alemseged F, Bedada W. Assessment of potential
drug-drug interactions among outpatients receiving cardiovascular
medications at Jimma University Specialized Hospital, South West
Ethiopia. Int J Basic Clin Pharmacol 2013;2(2):114-52.
Richards TR, Tobe SW. Combining other antihypertensive drugs with
ß-blockers in hypertension: A focus on safety and tolerability. Can J
Cardiol 2014;30 5 Suppl: S42-6.
Tornio A, Niemi M, Neuvonen PJ, Backman JT. Drug interactions with
oral antidiabetic agents: Pharmacokinetic mechanisms and clinical
implications. Trends Pharmacol Sci 2012;33(6):312-22.
Setter SM, Iltz JL, Thams J, Campbell RK. Metformin hydrochloride in
the treatment of type 2 diabetes mellitus: A clinical review with a focus
on dual therapy. Clin Ther 2003;25(12):2991-3026.
Devi JO, George KB, Cheriyan MH, Londhe SP, Vinay DM. To identify
and analyze potential drug-drug interactions from the medication charts
of medicine units of a tertiary care teaching hospital, Davangere. Int J
Pharm Res Sch (IJPRS) 2015;4(1):196-204.
Reimche L, Forster AJ, van Walraven C. Incidence and contributors
to potential drug-drug interactions in hospitalized patients. J Clin
Pharmacol 2011;51(7):1043-50.
Tripathi KD. Essentials of Medical Pharmacology. 6
ed. New Delhi:
Jaypee Brothers Medical Publishers; 2006.
Stockley IH. Stockley’s Drug Interactions. 8
th
th
ed. Great Britain:
Pharmaceutical Press; 2008.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.